GREM2 is associated with human central obesity and inhibits visceral preadipocyte browning
Wen Liu,Danjie Li,Minglan Yang,Long Wang,Yu Xu,Na Chen,Zhiyin Zhang,Juan Shi,Wen Li,Shaoqian Zhao,Aibo Gao,Yufei Chen,Qinyun Ma,Ruizhi Zheng,Shujing Wu,Yifei Zhang,Yuhong Chen,Shuwen Qian,Yufang Bi,Weiqiong Gu,Qiqun Tang,Guang Ning,Ruixin Liu,Weiqing Wang,Jie Hong,Jiqiu Wang
DOI: https://doi.org/10.1016/j.ebiom.2022.103969
IF: 11.205
2022-04-01
EBioMedicine
Abstract:SummaryBackgroundSome circulating proteins are linked to central adiposity. Gremlin 2 (GREM2) functions as a secreted factor involved in osteogenesis and adipogenesis. Here, we investigated the association of blood GREM2 levels and central adiposity, and the biological roles of GREM2 in the browning program of visceral preadipocytes.MethodsThree independent cohorts were applied to detect circulating GREM2 levels. Recombinant Grem2 protein, Grem2 overexpression and knockout mouse models, and preadipocyte-specific Bmpr2 knockout mice were used to assess the roles of Grem2 in the browning program.FindingsWe detected the presence of GREM2 protein in human serum using an ELISA approach. We revealed elevated GREM2 levels in severely obese subjects and validated this finding in a large-scale community population involving 10,327 subjects. Notably, serum GREM2 was positively associated with visceral fat volume, as quantified by 3D reconstruction methods. In mice, Grem2 was highly expressed in visceral fat and liver tissues, while surgical removal of visceral fat lowered circulating Grem2 levels. Visceral fat secreted more Grem2 in obese mice. Grem2-overexpressed mice exhibited a reduced browning ability of visceral fat, whereas Grem2 ablation enhanced the browning capacity and reduced visceral fat content. Mechanistically, Grem2 attenuated the browning program of visceral preadipocytes partially by antagonizing BMP4/7-SMAD1/5/8 signaling pathway. Further, genetic deletion of Bmpr2 in Pdgfrα+ preadipocytes abolished the antagonistic effect of Grem2.InterpretationThese findings indicate that GREM2 might function as a circulating protein factor associated with human visceral adiposity, and Grem2 inhibits the browning capacity of visceral preadipocytes partially by BMP4/7-BMPR2 signaling pathway.FundingThe complete list of funders can be found in the Acknowledgement section.
medicine, research & experimental